tiprankstipranks
Trending News
More News >
Parenteral Drugs (India) Limited (IN:PDPL)
:PDPL
India Market

Parenteral Drugs (India) Limited (PDPL) Financial Statements

Compare
0 Followers

Parenteral Drugs (India) Limited Financial Overview

Parenteral Drugs (India) Limited's market cap is currently ₹101.08M. The company's EPS TTM is ₹; its P/E ratio is ―; Parenteral Drugs (India) Limited is scheduled to report earnings on ―, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 22Mar 21Mar 20Mar 19Mar 18
Income Statement
Total Revenue₹ 84.96M₹ 121.53M₹ 240.25M₹ 319.98M₹ 2.17B
Gross Profit₹ 30.31M₹ 48.37M₹ 13.40M₹ 75.64M₹ 370.93M
Operating Income₹ 0.00₹ -290.99K₹ -320.32K₹ -867.78K₹ -425.13M
EBITDA₹ 372.69M₹ -117.09M₹ -144.39M₹ -162.40M₹ -12.93M
Net Income₹ -763.62M₹ -1.22B₹ -1.14B₹ -1.48B₹ -1.19B
Balance Sheet
Cash & Short-Term Investments₹ 1.00K₹ 569.89K₹ 1.08M₹ 953.02K₹ 764.25K
Total Assets₹ 4.84B₹ 5.68B₹ 5.52B₹ 5.41B₹ 8.90B
Total Debt₹ 1.07B₹ 10.72B₹ 9.46B₹ 8.40B₹ 8.25B
Net Debt₹ 1.07B₹ 10.72B₹ 9.46B₹ 8.40B₹ 8.24B
Total Liabilities₹ 13.08B₹ 12.51B₹ 11.13B₹ 9.87B₹ 10.27B
Stockholders' Equity₹ -8.24B₹ -6.83B₹ -5.61B₹ -4.47B₹ -1.36B
Cash Flow
Free Cash Flow₹ -4.83M₹ 1.25B₹ 1.12B₹ 4.77B₹ 1.66B
Operating Cash Flow₹ -4.83M₹ 1.25B₹ 1.12B₹ 4.77B₹ 1.67B
Investing Cash Flow₹ 647.25M₹ 618.56K₹ 789.25K₹ 965.77M₹ -6.18M
Financing Cash Flow₹ -642.99M₹ -1.25B₹ -1.12B₹ -5.74B₹ -1.67B
Currency in INR

Parenteral Drugs (India) Limited Earnings and Revenue History

Parenteral Drugs (India) Limited Debt to Assets

Parenteral Drugs (India) Limited Cash Flow

Parenteral Drugs (India) Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis